Indivumed Services’ Post

Illumina Connected Insights version 4.0 is out! Now supporting variant interpretation for somatic oncology assays at scale, enabling - powerful visualizations of fusions and other variants called from #DRAGEN; integration of #OncoKB, and more than 55 other knowledge sources; and new automation to help predict #oncogenicity based on recent guidelines. #Oncology #NGS #Bioinformatics #Interpretation https://lnkd.in/gBR5syP6 #sequencing #bioinformatics Illumina

Explore the latest oncology innovations: New analysis of 5,000+ Commercial Opportunity Projects from over 100 leading universities worldwide. Book your 30 min demo here: https://lnkd.in/dii3FECB #cancer #oncology #cancerresearch #drugdiscovery #drugdevelopment #1stoncology #biotech #pharma #immunooncology #clinicaltrials #academic #businessdevelopment #searchandevaluation #commercialopportunities

During a recent Trial Talk, oncologists, including Eric C. Santos, MD, gave their expert insights on the benefits of cancer clinical trials as they would present it to one of their patients considering clinical trials as a treatment option. Read the blog here: https://buff.ly/42ME4gN #clinicaltrials #oncology #pharma #biotech #cancerresearch #science #innovation #MD

#AACR24, here we come!   We can’t wait to share with you the latest from our #DrugDiscovery labs next Monday. Here’s a preview 👇    💡 Abstract 2945 / 20: Find out how our #FunctionalGenomicsCentre’s teams are reducing the experimental scale of #CRISPR screens by 50%.     💡 Abstract 3333 / 21: Learn about ASTX295, a potent inhibitor of the MDM2-p53 interaction currently under clinical investigation.     Are you presenting at #AACR24? Let us know where and when in the comments.    #OnMyHorizon #Oncology Steve Wedge, David Walter, Astex Pharmaceuticals and American Association for Cancer Research

Diamond Equity Research: Price Target $0.49 IMU: Receives Orphan Drug Designation for Bile Tract CancerTherapy and Reports Encouraging Blood Cancer Trial Outcomes Read the full Report here: https://lnkd.in/gT2Wis3r #IMU #Imugene #Imugene #AzerCel #CancerResearch #DLBCL #CAR_T #ImmunoOncology #Biotech #ClinicalTrials #CancerTreatment #Oncology #MedicalResearch #equityresearch #equityrelease

Katrina Pedersen, MD, shared her excitement about cancer clinical trials in myTRIAList's AZUR-1 study overview video. To keep up to date on the latest trial-overview videos in CancerCare's myTRIAList Trial Finder, subscribe to our YouTube channel here: https://buff.ly/4bDeAWs #oncology #clinicaltrials #pharma #md #biotech #cancerresearch

Antibody-Drug Conjugates (ADCs) are transforming cancer therapy by pairing precision targeting with potent cytotoxic effects. But developing these complex molecules is no simple task. Join Christoph Lederer, Head of Operations Separation & ELISA at Solvias, as he shares insights into the analytical hurdles of ADC development — from merging expertise in both small molecules and biologics to maintaining linker stability and achieving an optimal drug-to-antibody ratio (DAR). Ready to dive deeper? Access our latest white paper for a comprehensive look at the strategies needed to tackle ADC challenges and bring your innovation to its destination. 🔗 Download it now: https://lnkd.in/eTiBYqa9 #AntibodyDrugConjugates #ADCs #CancerResearch #Oncology

🌞 Ready to start the day at Frühjahrstagung ÖGPath in Vienna, Austria (7-9 March). Come say hi to Didier and learn more about our oncology test portfolio 🙋♂️ Want to be sure to get a slot? Book a meeting with us! 👉 https://lnkd.in/emzsJcvk https://lnkd.in/e5kGZzM6 #oncology #biocartis #diagnostics

Congratulations to the authors of this recent paper in Pharmaceuticals MDPI! With this latest addition to the literature, researchers have concluded that targeting Siglecs could pave the way for a new approach to immunotherapies in cancer treatment. #glycoimmunology #biotech #innovation #cancer  https://lnkd.in/duE6iHEA

On demand webinar on organoid drug screening! Click below to access. #OncoPro #Oncology #3Dmodeling